Free Trial

Senseonics (SENS) Stock Price, News & Analysis

-0.01 (-1.14%)
(As of 05/24/2024 08:00 PM ET)
Today's Range
50-Day Range
52-Week Range
1.09 million shs
Average Volume
2.35 million shs
Market Capitalization
$235.72 million
P/E Ratio
Dividend Yield
Price Target

Senseonics MarketRank™ Stock Analysis

Analyst Rating
2.00 Rating Score
181.5% Upside
$1.25 Price Target
Short Interest
Dividend Strength
News Sentiment
-0.22mentions of Senseonics in the last 14 days
Based on 2 Articles This Week
Insider Trading
Proj. Earnings Growth
From ($0.13) to ($0.11) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.64 out of 5 stars

Medical Sector

864th out of 921 stocks

Process Control Instruments Industry

12th out of 12 stocks

SENS stock logo

About Senseonics Stock (NYSE:SENS)

Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

SENS Stock Price History

SENS Stock News Headlines

Senseonics (NYSE:SENS) Coverage Initiated at
Senseonics: Q1 Earnings Snapshot
Senseonics Holdings Inc.
See More Headlines
Receive SENS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Senseonics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Fiscal Year End

Industry, Sector and Symbol

Process control instruments
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
2 Analysts


Net Income
Net Margins
Pretax Margin


Sales & Book Value

Annual Sales
$22.39 million
Book Value
$0.07 per share


Free Float
Market Cap
$235.72 million
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

SENS Stock Analysis - Frequently Asked Questions

Should I buy or sell Senseonics stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last twelve months. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" SENS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SENS, but not buy additional shares or sell existing shares.
View SENS analyst ratings
or view top-rated stocks.

What is Senseonics' stock price target for 2024?

2 Wall Street research analysts have issued 12 month price objectives for Senseonics' shares. Their SENS share price targets range from $0.50 to $2.00. On average, they predict the company's share price to reach $1.25 in the next year. This suggests a possible upside of 181.5% from the stock's current price.
View analysts price targets for SENS
or view top-rated stocks among Wall Street analysts.

How have SENS shares performed in 2024?

Senseonics' stock was trading at $0.5701 at the beginning of 2024. Since then, SENS stock has decreased by 22.1% and is now trading at $0.4440.
View the best growth stocks for 2024 here

How were Senseonics' earnings last quarter?

Senseonics Holdings, Inc. (NYSE:SENS) issued its earnings results on Thursday, February, 29th. The company reported ($0.03) EPS for the quarter, topping the consensus estimate of ($0.04) by $0.01. The firm earned $8 million during the quarter, compared to the consensus estimate of $7.62 million. Senseonics had a negative trailing twelve-month return on equity of 202.32% and a negative net margin of 346.38%.

What ETF holds Senseonics' stock?

Global X Telemedicine & Digital Health ETF holds 332,720 shares of SENS stock, representing 0.32% of its portfolio.

When did Senseonics IPO?

Senseonics (SENS) raised $45 million in an IPO on Friday, March 18th 2016. The company issued 15,800,000 shares at a price of $2.85 per share. Leerink Partners, Canaccord Genuity and Raymond James served as the underwriters for the IPO and BTIG was co-manager.

Who are Senseonics' major shareholders?

Senseonics' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (4.24%), Mirae Asset Global Investments Co. Ltd. (0.17%), Price T Rowe Associates Inc. MD (0.07%), Virtu Financial LLC (0.06%), State Board of Administration of Florida Retirement System (0.03%) and Newbridge Financial Services Group Inc. (0.03%). Insiders that own company stock include Anthony R Raab, Douglas A Roeder, Edward Fiorentino, Francine Kaufman, Mirasol Panlilio, Mukul Jain, Nick B Tressler, Sharon Larkin, Stephen P Defalco and Timothy T Goodnow.
View institutional ownership trends

How do I buy shares of Senseonics?

Shares of SENS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:SENS) was last updated on 5/27/2024 by Staff

From Our Partners